Healthcare >> CEO Interviews >> August 6, 2001
THOMAS A. BOLOGNA joined Ostex in July 1997 as the company's
President and Chief Executive Officer and became Chairman of the
Board of Directors in 1999. He has an extensive background as an
accomplished Chairman, President, Chief Executive Officer, and
senior executive at a number of well-known private and public
healthcare companies. He was President and Chief Executive
Officer of Scriptgen Pharmaceuticals, Inc., a Boston-based
biotechnology firm that he built and successfully led through
venture and corporate partnering transactions. Prior to
Scriptgen, Mr. Bologna was Chairman, CEO, and President of Gen-
Probe Incorporated, a leading San Diego-based company that
commercialized genetic probe-based technology for diagnostic and
therapeutic applications. Mr. Bologna took Gen-Probe public and
subsequently sold the company to Chugai Pharmaceutical Co. Ltd.
of Tokyo, Japan. Before leading Gen-Probe, Mr. Bologna held
several senior level positions with Becton, Dickinson & Company
and Warner Lambert Company. At Becton Dickinson he served as
President of the Diagnostic Instruments Systems Division,
President of the Johnston Laboratories Division, and Vice
President and General Manager of the Hynson Westcott & Dunning
biotechnology unit. At Warner Lambert, Mr. Bologna served as a
Vice President responsible for the marketing, sales and R&D
functions, as well as the Asia Pacific profit center for the
Scientific Instrument Division. Mr. Bologna received his BS from
the New York University School of Engineering and Science and his
MBA from New York University Graduate School of Business
Administration (Stern School of Management). Profile
with a description of what you see as the business and company today?
Mr. Bologna: What we do at Ostex is really quite
